Skip to content
Recall Observatory FDA recall evidence

Drug product

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

D-0620-2025

July 30, 2025

Class II

Product summary

Firm
Exela Pharma Sciences LLC
Event
Event 97348
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0620-2025

Official wording

Reason: Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

Code information: Lot # 10004077, Exp. 02/28/2026

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification